Industry: Medical Devices & Consumables
Published Date: 2024-12-29
Pages: 89 Pages
Report ld: 3414475
Request Sample
Customized Report
Nitinol Vascular Stent Market Size(US$)

CAGR 2024-2030
7.8%
Market Size,2030
USD 13,760
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Nitinol Vascular Stent was valued at US$ 8167 million in the year 2023 and is projected to reach a revised size of US$ 13760 million by 2030, growing at a CAGR of 7.8% during the forecast period.
Nitinol Vascular Stent is a medical device made from a Nitinol material that has shape memory and superelastic properties to expand inside blood vessels to support narrowed or blocked vessels and restore blood flow, and is commonly used to treat coronary artery disease, peripheral artery disease, and other vascular narrowing problems.
North American market for Nitinol Vascular Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nitinol Vascular Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nitinol Vascular Stent include Boston Scientific, Medtronic, Cordis, BD, Cook Medical, Gore & Associates, Abbott, Terumo, B. Braun Melsungen, Bolton Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nitinol Vascular Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol Vascular Stent.
The Nitinol Vascular Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitinol Vascular Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitinol Vascular Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitinol Vascular Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitinol Vascular Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Nitinol Vascular Stent Market Overview
1.1 Product Definition
1.2 Nitinol Vascular Stent by Type
1.2.1 Global Nitinol Vascular Stent Market Value Comparison by Type (2024-2030)
1.2.2 Balloon Expansion
1.2.3 Self Expanding
1.3 Nitinol Vascular Stent by Application
1.3.1 Global Nitinol Vascular Stent Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Centers
1.3.4 Others
1.4 Global Nitinol Vascular Stent Market Size Estimates and Forecasts
1.4.1 Global Nitinol Vascular Stent Revenue 2019-2030
1.4.2 Global Nitinol Vascular Stent Sales 2019-2030
1.4.3 Global Nitinol Vascular Stent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nitinol Vascular Stent Market Competition by Manufacturers
2.1 Global Nitinol Vascular Stent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nitinol Vascular Stent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nitinol Vascular Stent Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Nitinol Vascular Stent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nitinol Vascular Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitinol Vascular Stent, Product Type & Application
2.7 Global Key Manufacturers of Nitinol Vascular Stent, Date of Enter into This Industry
2.8 Global Nitinol Vascular Stent Market Competitive Situation and Trends
2.8.1 Global Nitinol Vascular Stent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nitinol Vascular Stent Players Market Share by Revenue
2.8.3 Global Nitinol Vascular Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nitinol Vascular Stent Market Scenario by Region
3.1 Global Nitinol Vascular Stent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nitinol Vascular Stent Sales by Region: 2019-2030
3.2.1 Global Nitinol Vascular Stent Sales by Region: 2019-2024
3.2.2 Global Nitinol Vascular Stent Sales by Region: 2025-2030
3.3 Global Nitinol Vascular Stent Revenue by Region: 2019-2030
3.3.1 Global Nitinol Vascular Stent Revenue by Region: 2019-2024
3.3.2 Global Nitinol Vascular Stent Revenue by Region: 2025-2030
3.4 North America Nitinol Vascular Stent Market Facts & Figures by Country
3.4.1 North America Nitinol Vascular Stent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nitinol Vascular Stent Sales by Country (2019-2030)
3.4.3 North America Nitinol Vascular Stent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nitinol Vascular Stent Market Facts & Figures by Country
3.5.1 Europe Nitinol Vascular Stent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nitinol Vascular Stent Sales by Country (2019-2030)
3.5.3 Europe Nitinol Vascular Stent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol Vascular Stent Market Facts & Figures by Region
3.6.1 Asia Pacific Nitinol Vascular Stent Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nitinol Vascular Stent Sales by Region (2019-2030)
3.6.3 Asia Pacific Nitinol Vascular Stent Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nitinol Vascular Stent Market Facts & Figures by Country
3.7.1 Latin America Nitinol Vascular Stent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nitinol Vascular Stent Sales by Country (2019-2030)
3.7.3 Latin America Nitinol Vascular Stent Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nitinol Vascular Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol Vascular Stent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nitinol Vascular Stent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nitinol Vascular Stent Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nitinol Vascular Stent Sales by Type (2019-2030)
4.1.1 Global Nitinol Vascular Stent Sales by Type (2019-2024)
4.1.2 Global Nitinol Vascular Stent Sales by Type (2025-2030)
4.1.3 Global Nitinol Vascular Stent Sales Market Share by Type (2019-2030)
4.2 Global Nitinol Vascular Stent Revenue by Type (2019-2030)
4.2.1 Global Nitinol Vascular Stent Revenue by Type (2019-2024)
4.2.2 Global Nitinol Vascular Stent Revenue by Type (2025-2030)
4.2.3 Global Nitinol Vascular Stent Revenue Market Share by Type (2019-2030)
4.3 Global Nitinol Vascular Stent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nitinol Vascular Stent Sales by Application (2019-2030)
5.1.1 Global Nitinol Vascular Stent Sales by Application (2019-2024)
5.1.2 Global Nitinol Vascular Stent Sales by Application (2025-2030)
5.1.3 Global Nitinol Vascular Stent Sales Market Share by Application (2019-2030)
5.2 Global Nitinol Vascular Stent Revenue by Application (2019-2030)
5.2.1 Global Nitinol Vascular Stent Revenue by Application (2019-2024)
5.2.2 Global Nitinol Vascular Stent Revenue by Application (2025-2030)
5.2.3 Global Nitinol Vascular Stent Revenue Market Share by Application (2019-2030)
5.3 Global Nitinol Vascular Stent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Nitinol Vascular Stent Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Nitinol Vascular Stent Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Cordis
6.3.1 Cordis Company Information
6.3.2 Cordis Description and Business Overview
6.3.3 Cordis Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cordis Nitinol Vascular Stent Product Portfolio
6.3.5 Cordis Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Nitinol Vascular Stent Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Cook Medical
6.5.1 Cook Medical Company Information
6.5.2 Cook Medical Description and Business Overview
6.5.3 Cook Medical Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cook Medical Nitinol Vascular Stent Product Portfolio
6.5.5 Cook Medical Recent Developments/Updates
6.6 Gore & Associates
6.6.1 Gore & Associates Company Information
6.6.2 Gore & Associates Description and Business Overview
6.6.3 Gore & Associates Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gore & Associates Nitinol Vascular Stent Product Portfolio
6.6.5 Gore & Associates Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Abbott Nitinol Vascular Stent Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Terumo Nitinol Vascular Stent Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Company Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B. Braun Melsungen Nitinol Vascular Stent Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 Bolton Medical
6.10.1 Bolton Medical Company Information
6.10.2 Bolton Medical Description and Business Overview
6.10.3 Bolton Medical Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bolton Medical Nitinol Vascular Stent Product Portfolio
6.10.5 Bolton Medical Recent Developments/Updates
6.11 LifeTech Scientific
6.11.1 LifeTech Scientific Company Information
6.11.2 LifeTech Scientific Description and Business Overview
6.11.3 LifeTech Scientific Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LifeTech Scientific Nitinol Vascular Stent Product Portfolio
6.11.5 LifeTech Scientific Recent Developments/Updates
6.12 MicroPort
6.12.1 MicroPort Company Information
6.12.2 MicroPort Description and Business Overview
6.12.3 MicroPort Nitinol Vascular Stent Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Nitinol Vascular Stent Product Portfolio
6.12.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol Vascular Stent Industry Chain Analysis
7.2 Nitinol Vascular Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol Vascular Stent Production Mode & Process
7.4 Nitinol Vascular Stent Sales and Marketing
7.4.1 Nitinol Vascular Stent Sales Channels
7.4.2 Nitinol Vascular Stent Distributors
7.5 Nitinol Vascular Stent Customers
8 Nitinol Vascular Stent Market Dynamics
8.1 Nitinol Vascular Stent Industry Trends
8.2 Nitinol Vascular Stent Market Drivers
8.3 Nitinol Vascular Stent Market Challenges
8.4 Nitinol Vascular Stent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Nitinol Vascular Stent market is projected to grow from US$ 1498 million in 2025 to US$ 2739 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 203
USD 4900.00
(Single User License)
The global Nitinol Vascular Stent market size was US$ 1498 million in 2025 and is forecast to reach a readjusted size of US$ 2739 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 128
USD 4250.00
(Single User License)
The global market for Nitinol Vascular Stent was estimated to be worth US$ 1498 million in 2025 and is projected to reach US$ 2739 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 184
USD 3950.00
(Single User License)
The global Nitinol Vascular Stent market was valued at US$ 1498 million in 2025 and is anticipated to reach US$ 2739 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 150
USD 2900.00
(Single User License)
The global Nitinol Vascular Stent market size was US$ 8771 million in 2024 and is forecast to a readjusted size of US$ 14730 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 99
USD 4250.00
(Single User License)
The global Nitinol Vascular Stent market is projected to grow from US$ 8771 million in 2024 to US$ 14730 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 156
USD 4900.00
(Single User License)
The global market for Nitinol Vascular Stent was estimated to be worth US$ 8771 million in 2024 and is forecast to a readjusted size of US$ 14730 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
The global market for Nitinol Vascular Stent was valued at US$ 8771 million in the year 2024 and is projected to reach a revised size of US$ 14730 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
The global Nitinol Vascular Stent revenue was US$ 8167 million in 2023 and is forecast to a readjusted size of US$ 13760 million by 2030 with a CAGR of 7.8% during the review period (2024-2030).
Published Date: 2024-12-29
Pages: 140
USD 4350.00
(Single User License)
Valued at US$ 8771 million in 2024, the global Nitinol Vascular Stent market is forecast to reach US$ 13760 million by 2030, at a CAGR of 7.8% during the forecast period.
Published Date: 2024-12-29
Pages: 155
USD 4900.00
(Single User License)
The global Nitinol Vascular Stent market is projected to grow from US$ 1498 million in 2025 to US$ 2739 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 203
The global Nitinol Vascular Stent market size was US$ 1498 million in 2025 and is forecast to reach a readjusted size of US$ 2739 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 128
The global market for Nitinol Vascular Stent was estimated to be worth US$ 1498 million in 2025 and is projected to reach US$ 2739 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-03-15
Pages: 184
The global Nitinol Vascular Stent market was valued at US$ 1498 million in 2025 and is anticipated to reach US$ 2739 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-03-15
Pages: 150
The global Nitinol Vascular Stent market size was US$ 8771 million in 2024 and is forecast to a readjusted size of US$ 14730 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 99
The global Nitinol Vascular Stent market is projected to grow from US$ 8771 million in 2024 to US$ 14730 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 156
The global market for Nitinol Vascular Stent was estimated to be worth US$ 8771 million in 2024 and is forecast to a readjusted size of US$ 14730 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
The global market for Nitinol Vascular Stent was valued at US$ 8771 million in the year 2024 and is projected to reach a revised size of US$ 14730 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-03-10
Pages: 97
The global Nitinol Vascular Stent revenue was US$ 8167 million in 2023 and is forecast to a readjusted size of US$ 13760 million by 2030 with a CAGR of 7.8% during the review period (2024-2030).
Published: 2024-12-29
Pages: 140
Valued at US$ 8771 million in 2024, the global Nitinol Vascular Stent market is forecast to reach US$ 13760 million by 2030, at a CAGR of 7.8% during the forecast period.
Published: 2024-12-29
Pages: 155
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now